Literature DB >> 20977430

Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: role of NADPH oxidase.

Rocío López-Sepúlveda1, Manuel Gómez-Guzmán, Maria José Zarzuelo, Miguel Romero, Manuel Sánchez, Ana María Quintela, Pilar Galindo, Francisco O'Valle, Juan Tamargo, Francisco Pérez-Vizcaíno, Juan Duarte, Rosario Jiménez.   

Abstract

RWPs (red wine polyphenols) exert antihypertensive effects and improve endothelial function by reducing the plasma levels of ET-1 (endothelin-1) and the subsequent vascular production of O(2)(•-) (superoxide anion). Our present study was designed to evaluate whether RWPs act directly in the vascular wall improving endothelial dysfunction and O(2)(•-) production induced by ET-1 and to analyse the compounds responsible for these protective effects. We incubated rat isolated aortic rings in the presence or absence of ET-1 (10 nM) and RWPs (10(-4) to 10(-2) g/l) or catechin (0.2 μM), epicatechin (10 μM) and resveratrol (0.1 μM). ET-1 reduced the relaxant responses to acetylcholine, increased intracellular O(2)(•-) production, NADPH oxidase activity and protein expression of NADPH oxidase subunit p47phox. All these changes were prevented by RWPs. The preventive effects of RWPs were unaffected by co-incubation with either ICI-182780, an ER (oestrogen receptor) antagonist, or GW9662, a PPARγ (peroxisome-proliferator-activated receptor γ) antagonist. RWPs inhibited the phosphorylation of the mitogen-activated protein kinase, ERK1/2 (extracellular signal-regulated kinase 1/2), a key regulator of p47phox expression in response to ET-1. When the isolated polyphenols were tested, at the concentrations found in 10(-2) g/l RWPs, only epicatechin prevented endothelial dysfunction and all biochemical changes induced by ET-1 in the vascular wall. Taken together, these results indicate that RWPs prevent ET-1-induced vascular O(2)(•-) production by reducing overexpression of p47phox and the subsequent increased NADPH oxidase activity, leading to improvement in endothelial function. The effects of RWPs appear to be independent of ER and PPARγ activation and are related to ERK1/2 inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20977430     DOI: 10.1042/CS20100311

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

Review 1.  Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?

Authors:  Katarzyna Goszcz; Garry G Duthie; Derek Stewart; Stephen J Leslie; Ian L Megson
Journal:  Br J Pharmacol       Date:  2017-02-02       Impact factor: 8.739

Review 2.  Nutritional recommendations for individuals with Flammer syndrome.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Jerome Bovet; Maneli Mozaffarieh
Journal:  EPMA J       Date:  2017-05-29       Impact factor: 6.543

3.  Age and exercise training alter signaling through reactive oxygen species in the endothelium of skeletal muscle arterioles.

Authors:  Amy L Sindler; Rafael Reyes; Bei Chen; Payal Ghosh; Alvaro N Gurovich; Lori S Kang; Arturo J Cardounel; Michael D Delp; Judy M Muller-Delp
Journal:  J Appl Physiol (1985)       Date:  2013-01-03

Review 4.  The vascular endothelium in diabetes--a therapeutic target?

Authors:  Kieren J Mather
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

5.  Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.

Authors:  Karla G G Serafim; Suelen A Navarro; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Victor Fattori; Thiago M Cunha; Jose C Alves-Filho; Fernando Q Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-06       Impact factor: 3.000

Review 6.  Current status of NADPH oxidase research in cardiovascular pharmacology.

Authors:  Bruno K Rodiño-Janeiro; Beatriz Paradela-Dobarro; María Isabel Castiñeiras-Landeira; Sergio Raposeiras-Roubín; José R González-Juanatey; Ezequiel Alvarez
Journal:  Vasc Health Risk Manag       Date:  2013-07-25

7.  Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts.

Authors:  Emilia Wojtera; Anna Konior; Natalia Fedoryszak-Kuśka; Andrzej Beręsewicz
Journal:  Int J Mol Sci       Date:  2014-10-27       Impact factor: 5.923

8.  Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes.

Authors:  Krasimir Kostov; Alexander Blazhev; Milena Atanasova; Anelia Dimitrova
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

Review 9.  The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.

Authors:  Agata Kowalczyk; Paulina Kleniewska; Michal Kolodziejczyk; Beata Skibska; Anna Goraca
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-10-07       Impact factor: 4.291

Review 10.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.